INSMED INC (INSM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for INSM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INSM | Lead Independent Director | 72 | ["More than 50 years of experience in the pharmaceutical industry", "Experience at public pharmaceutical companies", "Board experience and roles in executive management, commercialization, and product management"] | ["Compensation", "Chair of the Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 72 Director Since: May 2014 Lead Independent Director Since: November 2018 Committee: Chair of the Compensation Committee Recent Public Board Service: Chairman of the Board of Directors until 2021, Alexion Pharmaceuticals (Formerly, Nasdaq: ALXN) Qualifications: Mr. Brennan has more than 50 years of experience in the pharmaceutical industry. The Board believes that Mr. Brennan s experience at public pharmaceutical companies, including board experience and roles in executive management, commercialization, and product management, makes him a valuable asset to the Board. Education: Gettysburg College B.A., business administration Career Highlights: Alexion (2014 - 2021) Chairman until acquisition by AstraZeneca PLC Interim CEO (2016 2017) Director AstraZeneca PLC (NYSE: AZN) (1999 - 2012) CEO Executive Vice President of North America Senior Vice President of Commercialization and Portfolio Management Director Astra Merck, Inc. (1995 - 1999) Merck & Co., Inc. (1975 - 1994)